We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

13th June 2013
Selected Chemistry & Industry magazine issue

Select an Issue

C&I Magazine

C&I e-books

C&I e-books

C&I apps

iOS App
Android App

News

Shale gas boom or bust?

Maria Burke, June 2013

The size of shale gas resources in the US and the Europe has been vastly over-exaggerated, according to a Canadian geoscientist

Feature

Nicotine patch

Patch works

Emma Dorey, June 2013

Drug delivery through the skin is minimally invasive and virtually painless. However, getting drugs across the skin is technically difficult

Webinars

Product Focus

Metrohm Product Focus
Action on droughtJune 19, 2013

Leader

Rosy tint?

Neil Eisberg, June 2013

A couple of months ago, Andrew Liveris, chairman and ceo of Dow Chemical, said a global manufacturing renaissance is within reach

Reviews

A tarnished image?

John Mann, June 2013

In the last century, it was unthinkable that the pharmaceutical industry would be described as ‘devalued and distrusted’

Comment

Is China’s innovation a serious challenge?

Dieter Ernst, June 2013

Fears are widespread in the US, Europe and Japan that China’s rise in industrial manufacturing and innovation will challenge incumbent global leaders

People

Movers & shakers

June 2013
Mark Aston

Biopharmaceutical company SuppreMol, which is developing novel therapies for the treatment of autoimmune diseases, has appointed Klaus Schollmeier as ceo

Highlights

Biomedical highlights

Kevin Burgess, June 2013

Determining if, how and where a small molecule ligand binds a protein tends to be highly problematic

Twitter Facebook